KOL Commentary

SABCS Symposium 2023 Highlights

View the latest research highlights from the 2023 edition of the San Antonio Breast Cancer Symposium.
Those exclusive insights are provided to you by our esteemed experts Dr. Roland CY Leung, Dr. Chun-Yu Liu, Prof. Sherene Loi, Prof. Bruce Mann, and Prof. Nick Zdenkowski.
Explore these highlights to enhance your clinical practice and stay updated on the latest advancements.

Promising new therapeutic agent

Explore a promising new therapeutic option, Dato-DXd, for patients with hormone receptor-positive, HER2-negative breast cancer. Learn about the results from the TROPION-Breast01 trial, offering insights into its efficacy and safety profile compared to chemotherapy.

Updates on important clinical trials

Stay updated on critical clinical trials shaping breast cancer treatment approaches. Explore the latest findings on adjuvant therapies such as ribociclib, ado-trastuzumab emtansine, TDM-1, and pembrolizumab, and understand their potential impact on patient care.

Biomarker, monitoring, and predictive values

Discover the importance of biomarkers in breast cancer care through insightful studies. Learn about the role of ctDNA detection, biomarker monitoring, and predictive values in guiding treatment decisions for better patient outcomes.

New drug approvals for metastatic breast cancer

Stay informed about recent advancements in metastatic breast cancer treatment with a discussion on newly approved drugs. Explore how these innovations are offering hope and improved outcomes for patients facing this challenging condition.

Benefit of immunotherapy for early-stage high-risk ER+/HER2− breast cancer

Explore the potential of immunotherapy in early-stage high-risk ER+/HER2− breast cancer, uncovering its role in revolutionizing treatment paradigms and improving patient outcomes.

Surgical approach and radiotherapy

Gain valuable insights into surgical approaches and radiotherapy strategies for breast cancer patients. Explore the impact of bilateral mastectomy on survival, particularly in individuals with a BRCA1 mutation, through an international analysis of treatment outcomes.

Pathophysiology and biology of breast cancer

Delve into the intricate workings of breast cancer biology with a focus on its pathophysiology, evolution, and metastasis mechanisms. Gain insights into the development of triple-negative breast cancer, exploring its proliferation mechanisms and evasion of apoptosis.

How would you rate this content?

This site is only for use by healthcare professionals.
By continuing to view this site you are confirming that you are a healthcare professional.

Confirm